BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16264332)

  • 1. Cytokine-mediated signalling and early defects in lymphoid development.
    Giliani S; Mella P; Savoldi G; Mazzolari E
    Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):519-24. PubMed ID: 16264332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe combined immunodeficiencies of the common gamma-chain/JAK3 signaling pathway.
    Schumacher RF; Notarangelo LD
    Isr Med Assoc J; 2002 Feb; 4(2):131-5. PubMed ID: 11875988
    [No Abstract]   [Full Text] [Related]  

  • 3. Jak3 and the pathogenesis of severe combined immunodeficiency.
    O'Shea JJ; Husa M; Li D; Hofmann SR; Watford W; Roberts JL; Buckley RH; Changelian P; Candotti F
    Mol Immunol; 2004 Jul; 41(6-7):727-37. PubMed ID: 15220007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency.
    Laffort C; Le Deist F; Favre M; Caillat-Zucman S; Radford-Weiss I; Debré M; Fraitag S; Blanche S; Cavazzana-Calvo M; de Saint Basile G; de Villartay JP; Giliani S; Orth G; Casanova JL; Bodemer C; Fischer A
    Lancet; 2004 Jun; 363(9426):2051-4. PubMed ID: 15207958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model.
    Notarangelo LD; Giliani S; Mella P; Schumacher RF; Mazza C; Savoldi G; Rodriguez-Pérez C; Badolato R; Mazzolari E; Porta F; Candotti F; Ugazio AG
    Immunobiology; 2000 Aug; 202(2):106-19. PubMed ID: 10993286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines and immunodeficiency diseases.
    Leonard WJ
    Nat Rev Immunol; 2001 Dec; 1(3):200-8. PubMed ID: 11905829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.
    Candotti F; O'Shea JJ; Villa A
    Springer Semin Immunopathol; 1998; 19(4):401-15. PubMed ID: 9618765
    [No Abstract]   [Full Text] [Related]  

  • 8. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model.
    Notarangelo LD; Giliani S; Mazza C; Mella P; Savoldi G; Rodriguez-Pérez C; Mazzolari E; Fiorini M; Duse M; Plebani A; Ugazio AG; Vihinen M; Candotti F; Schumacher RF
    Immunol Rev; 2000 Dec; 178():39-48. PubMed ID: 11213805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Jak3 in lymphoid development, activation, and signaling.
    Thomis DC; Berg LJ
    Curr Opin Immunol; 1997 Aug; 9(4):541-7. PubMed ID: 9287175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune deficiencies due to defects in cytokine signaling.
    Kelly J; Leonard WJ
    Curr Allergy Asthma Rep; 2003 Sep; 3(5):396-401. PubMed ID: 12906775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid protein-based assays for the diagnosis of T-B+ severe combined immunodeficiency.
    Gilmour KC; Cranston T; Loughlin S; Gwyther J; Lester T; Espanol T; Hernandez M; Savoldi G; Davies EG; Abinun M; Kinnon C; Jones A; Gaspar HB
    Br J Haematol; 2001 Mar; 112(3):671-6. PubMed ID: 11260071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
    Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
    EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.
    Notarangelo LD; Mella P; Jones A; de Saint Basile G; Savoldi G; Cranston T; Vihinen M; Schumacher RF
    Hum Mutat; 2001 Oct; 18(4):255-63. PubMed ID: 11668610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lymphoid development in the absence of common γ-chain receptor signaling.
    Kohn LA; Seet CS; Scholes J; Codrea F; Chan R; Zaidi-Merchant S; Zhu Y; De Oliveira S; Kapoor N; Shah A; Abdel-Azim H; Kohn DB; Crooks GM
    J Immunol; 2014 Jun; 192(11):5050-8. PubMed ID: 24771849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new modality for immunosuppression: targeting the JAK/STAT pathway.
    O'Shea JJ; Pesu M; Borie DC; Changelian PS
    Nat Rev Drug Discov; 2004 Jul; 3(7):555-64. PubMed ID: 15232577
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel mutant gammac chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action.
    Kumaki S; Ochs HD; Kuropatwinski KK; Konno T; Timour MS; Cosman D; Baumann H
    Clin Exp Immunol; 1999 Feb; 115(2):356-61. PubMed ID: 9933465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The γ
    Leonard WJ; Lin JX; O'Shea JJ
    Immunity; 2019 Apr; 50(4):832-850. PubMed ID: 30995502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells.
    Kirken RA; Erwin RA; Taub D; Murphy WJ; Behbod F; Wang L; Pericle F; Farrar WL
    J Leukoc Biol; 1999 Jun; 65(6):891-9. PubMed ID: 10380915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency.
    Vihinen M; Villa A; Mella P; Schumacher RF; Savoldi G; O'Shea JJ; Candotti F; Notarangelo LD
    Clin Immunol; 2000 Aug; 96(2):108-18. PubMed ID: 10900158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Common Cytokine Receptor γ Chain Family of Cytokines.
    Lin JX; Leonard WJ
    Cold Spring Harb Perspect Biol; 2018 Sep; 10(9):. PubMed ID: 29038115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.